213 related articles for article (PubMed ID: 24117640)
1. The esophageal mucosa and submucosa: immunohistology in GERD and Barrett's esophagus.
Appelman HD; Streutker C; Vieth M; Neumann H; Neurath MF; Upton MP; Sagaert X; Wang HH; El-Zimaity H; Abraham SC; Bellizzi AM
Ann N Y Acad Sci; 2013 Oct; 1300():144-165. PubMed ID: 24117640
[TBL] [Abstract][Full Text] [Related]
2. Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa.
Eda A; Osawa H; Satoh K; Yanaka I; Kihira K; Ishino Y; Mutoh H; Sugano K
J Gastroenterol; 2003; 38(1):14-22. PubMed ID: 12560917
[TBL] [Abstract][Full Text] [Related]
3. Tissue resistance in the normal and diseased esophagus.
Bellizzi AM; Nardone G; Compare D; Bor S; Capanoglu D; Farré R; Neumann H; Neurath MF; Vieth M; Chen H; Chen X
Ann N Y Acad Sci; 2013 Oct; 1300():200-212. PubMed ID: 24117643
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of Barrett's esophagus.
Chandrasoma P
Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):270-8. PubMed ID: 9263345
[TBL] [Abstract][Full Text] [Related]
5. CDX2 and LI-cadherin expression in esophageal mucosa: use of both markers can facilitate the histologic diagnosis of Barrett's esophagus and carcinoma.
Weimann A; Zimmermann M; Gross M; Slevogt H; Rieger A; Morawietz L
Int J Surg Pathol; 2010 Oct; 18(5):330-7. PubMed ID: 20444732
[TBL] [Abstract][Full Text] [Related]
6. Double muscularis mucosae in Barrett's esophagus.
Takubo K; Sasajima K; Yamashita K; Tanaka Y; Fujita K
Hum Pathol; 1991 Nov; 22(11):1158-61. PubMed ID: 1743701
[TBL] [Abstract][Full Text] [Related]
7. Squamous mucosa overlying columnar epithelium in Barrett's esophagus in the absence of anti-reflux surgery.
Sampliner RE; Steinbronn K; Garewal HS; Riddell RH
Am J Gastroenterol; 1988 May; 83(5):510-2. PubMed ID: 3364411
[TBL] [Abstract][Full Text] [Related]
8. Acid and bile salt-induced CDX2 expression differs in esophageal squamous cells from patients with and without Barrett's esophagus.
Huo X; Zhang HY; Zhang XI; Lynch JP; Strauch ED; Wang JY; Melton SD; Genta RM; Wang DH; Spechler SJ; Souza RF
Gastroenterology; 2010 Jul; 139(1):194-203.e1. PubMed ID: 20303354
[TBL] [Abstract][Full Text] [Related]
9. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
[TBL] [Abstract][Full Text] [Related]
10. Expression of CDX2 and MUC2 in Barrett's mucosa.
Steininger H; Pfofe DA; Müller H; Haag-Sunjic G; Fratianu V
Pathol Res Pract; 2005; 201(8-9):573-7. PubMed ID: 16259110
[TBL] [Abstract][Full Text] [Related]
11. Microscopic esophagitis and Barrett's esophagus: the histology report.
Fiocca R; Mastracci L; Milione M; Parente P; Savarino V; ;
Dig Liver Dis; 2011 Mar; 43 Suppl 4():S319-30. PubMed ID: 21459338
[TBL] [Abstract][Full Text] [Related]
12. Differences in ERK activation in squamous mucosa in patients who have gastroesophageal reflux disease with and without Barrett's esophagus.
Souza RF; Shewmake KL; Shen Y; Ramirez RD; Bullock JS; Hladik CL; Lee EL; Terada LS; Spechler SJ
Am J Gastroenterol; 2005 Mar; 100(3):551-9. PubMed ID: 15743351
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin expression in gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma: an immunohistochemical and immunoblot study.
Swami S; Kumble S; Triadafilopoulos G
Am J Gastroenterol; 1995 Oct; 90(10):1808-13. PubMed ID: 7572899
[TBL] [Abstract][Full Text] [Related]
14. Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagus.
Stairs DB; Nakagawa H; Klein-Szanto A; Mitchell SD; Silberg DG; Tobias JW; Lynch JP; Rustgi AK
PLoS One; 2008; 3(10):e3534. PubMed ID: 18953412
[TBL] [Abstract][Full Text] [Related]
15. Defining esophageal landmarks, gastroesophageal reflux disease, and Barrett's esophagus.
DeVault K; McMahon BP; Celebi A; Costamagna G; Marchese M; Clarke JO; Hejazi RA; McCallum RW; Savarino V; Zentilin P; Savarino E; Thomson M; Souza RF; Donohoe CL; O'Farrell NJ; Reynolds JV
Ann N Y Acad Sci; 2013 Oct; 1300():278-295. PubMed ID: 24117649
[TBL] [Abstract][Full Text] [Related]
16. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
17. Pericentriolar material analyses in normal esophageal mucosa, Barrett's metaplasia and adenocarcinoma.
Segat D; Cassaro M; Dazzo E; Cavallini L; Romualdi C; Salvador R; Vitale MP; Vitiello L; Fassan M; Rugge M; Zaninotto G; Ancona E; Baroni MD
Histol Histopathol; 2010 May; 25(5):551-60. PubMed ID: 20238294
[TBL] [Abstract][Full Text] [Related]
18. Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus.
Vallböhmer D; DeMeester SR; Peters JH; Oh DS; Kuramochi H; Shimizu D; Hagen JA; Danenberg KD; Danenberg PV; DeMeester TR; Chandrasoma PT
Dis Esophagus; 2006; 19(4):260-6. PubMed ID: 16866857
[TBL] [Abstract][Full Text] [Related]
19. P53 and Ki-67 overexpression in gastroesophageal reflux disease--Barrett's esophagus and adenocarcinoma sequence.
Binato M; Gurski RR; Fagundes RB; Meurer L; Edelweiss MI
Dis Esophagus; 2009; 22(7):588-95. PubMed ID: 19302208
[TBL] [Abstract][Full Text] [Related]
20. Muscularis mucosae duplication and the musculo-fibrous anomaly in endoscopic mucosal resections for barrett esophagus: implications for staging of adenocarcinoma.
Lewis JT; Wang KK; Abraham SC
Am J Surg Pathol; 2008 Apr; 32(4):566-71. PubMed ID: 18300796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
